BGMA Warns Over US Trade Deal
UK Must Not Put NHS At Risk, Association Says
Warwick Smith, director general of the British Generic Manufacturers Association, has warned of increased costs and risks to the NHS due to intellectual property requirements sought by the US as part of a free trade agreement with the UK.
You may also be interested in...
Three Brexit deadlines have come and gone, and the UK is still a member of the European Union. It will remain so until it agrees a withdrawal deal or leaves without one at the end of January 2020. Alternatively, it could secure yet another extension to the Article 50 period beyond January 31. Or it could decide not to leave at all.
Gene Techno Science and Kishi Kasei have struck a deal to jointly develop a Japanese aflibercept biosimilar rival to Eylea.
Krka has revealed its new growth strategy for 2020-2024, including growing through joint ventures, partnerships and acquisitions and focusing on European, central Asian and Chinese markets. At the same time, the Slovenian firm has reported that its sales jumped by 12% in the first nine months of 2019.